Insights into (S)-rivastigmine inhibition of butyrylcholinesterase (BuChE): Molecular docking and saturation transfer difference NMR (STD-NMR)
Rivastigmine is a very important drug prescribed for the treatment of Alzheimer's disease (AD) symptoms. It is a dual inhibitor, in that it inhibits both acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). For our screening program on the discovery of new rivastigmine analogue hits f...
| Main Author: | |
|---|---|
| Other Authors: | , , |
| Format: | article |
| Language: | por |
| Published: |
2017
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10174/19819 |
| Country: | Portugal |
| Oai: | oai:dspace.uevora.pt:10174/19819 |